SecBot SecBot
8-K ·Filed Nov 5, 2026

AHR

American Healthcare REIT, Inc.
BULLISH
Impact 6/10
Horizonweeks Processed11d 11h ago SEC0001193125-26-449893
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

The raised guidance and strong Same-Store NOI growth across SHOP and ISHC segments signal continued operational momentum. Watch for execution on the >$1.0B investment pipeline expected to close by Q1 2027 and the pace of ATM share issuance given ~$1.32B in unsettled forward sale agreements.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

BULLISH VIEWSTOCK BELOW ENTRY AT T+5
Entry
$57.91
T+0 close · Nov 5, 2026 · via day close
Latest settled
−0.22%
T+5 · $57.78 · next T+20 in 20d
Vs SPY
−2.82%
α at T+5
Latest observation
+0.75%
T+6 · FF3 residual α
  1. T+0 · Nov 6 $57.91entry
  2. T+1 · 8d ago +1.81%α −0.55% · $58.96
  3. T+5 · 4d ago −0.22%α −2.82% · $57.78
  4. T+6 · todayOpen
  5. T+20 · in 20d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

American Healthcare REIT reported Q3 2026 NFFO of $0.58 per diluted share, above the $0.56 consensus, and raised full-year 2026 NFFO guidance to $2.23-$2.26 per share (from $2.15-$2.19). Total portfolio Same-Store NOI grew 13.8% YoY, led by SHOP (+28.2%) and ISHC (+15.7%). The company acquired $1.69B of SHOP assets in Q3 and completed a $819M follow-on equity offering, ending the quarter with Net Debt-to-Annualized Adjusted EBITDA of 1.9x.

Key Financial Metrics

EPS (AFFO/FFO)
$0.58
est $0.56 · +3.6% · GAAP: $0.14
Revenue
$742.1M
est $724.8M · +2.4% · +29.5% YoY
Rating
beat

Key Facts

  • Q3 2026 NFFO per diluted share of $0.58 vs consensus $0.56 (beat)
  • Full-year 2026 NFFO guidance raised to $2.23-$2.26 per share from $2.15-$2.19
  • Total portfolio Same-Store NOI growth of 13.8% YoY in Q3
  • SHOP Same-Store NOI growth of 28.2% YoY; ISHC Same-Store NOI growth of 15.7%
  • Acquired 17 SHOP assets for ~$1.69B in Q3; YTD 2026 investments total ~$2.07B
  • Completed August 2026 follow-on equity offering for ~$819M in gross proceeds
  • Net Debt-to-Annualized Adjusted EBITDA improved to 1.9x from 2.5x at June 30, 2026
  • Total liquidity of ~$2.35B as of September 30, 2026
  • Q3 2026 GAAP net income attributable to controlling interest of $31.2M, or $0.14 per diluted share
  • Quarterly cash distribution of $0.25 per share declared and paid

Financial Impact

Q3 NFFO $0.58 vs $0.56 consensus; FY 2026 NFFO guidance raised to $2.23-$2.26 midpoint $2.245 vs prior $2.15-$2.19 midpoint $2.17; Same-Store NOI growth guidance raised to 12.0%-14.0% from 11.0%-13.0%

nffosame-store noiguidancenet debt-to-ebitda

Segment Breakdown

SegmentRevenueGrowth
ISHC$345.5M+4.8%
SHOP$74.9M+9.0%
Outpatient Medical$28.5M+2.7%
Triple-Net Leased Properties$8.0M+1.4%

Risk Factors

  • Significant share dilution from ATM and follow-on offerings (231.5M shares outstanding at Sep 30, 2026 vs 185.9M at Dec 31, 2025)
  • Execution risk on deploying the >$1.0B investment pipeline and integrating 17 new SHOP assets
  • Interest rate exposure on $550M term loan maturing in 2027 with floating-rate swaps expiring January 2027
  • Dependence on operator partners (Trilogy Management Services operates 100% of ISHC segment)

Market Snapshot

Exchange
NYSE
Sector
Real Estate Investment Trusts
Analyst Consensus
95% bullish (19 analysts)

Investment Themes

Real Estate

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-449893
Document: ahr-ex99_1.htm0001193125-26-449893
Document: ahr-20261105.htm0001193125-26-449893
Document: 0001193125-26-449893-index-headers.html0001193125-26-449893
Document: 0001193125-26-449893-index.html0001193125-26-449893
Document: 0001193125-26-449893.txt0001193125-26-449893
8-K Data (Synthetic)0001193125-26-449893

Track record

17 reports on AHR

Performance horizon

3 of 4 bullish or bearish reports moved the stock their way by T+20. Best: +16.64% at T+60 after the Jun 11, 2026 report. 5 of 6 went positive at some point.

Filters
  1. Nov 10, 20266d ago 144 Neutral 2/10 Entry $59.23 Now $58.07 −1.96% settles Dec 10
  2. Nov 6, 202610d ago 8-K Bearish 5/10 Entry $58.96 Now $58.07 +1.51% settles Dec 8
  3. Nov 6, 202610d ago 424B5 Bearish 5/10 Entry $58.96 Now $58.07 +1.51% settles Dec 8
  4. Nov 5, 202611d ago 8-K Bullish 6/10 Viewing Entry $57.91 Now $58.07 +0.28% settles Dec 7
  5. Oct 29, 202618d ago Institutional Cluster Neutral 2/10 Entry $52.94 Now $58.07 +9.69% settles Nov 27
  6. Sep 18, 20268w ago 8-K Neutral 2/10 Entry $52.05 to $52.45 Now $58.07 +11.57% ▲ +0.77% +1.68% vs SPY
  7. Sep 14, 20269w ago 8-K Neutral 2/10 Entry $53.40 to $52.52 Now $58.07 +8.75% ▼ −1.65% −3.91% vs SPY
  8. Aug 24, 202612w ago 8-K Neutral 4/10 Entry $57.05 to $51.70 Now $58.07 +1.79% ▼ −9.38% −10.35% vs SPY
  9. Aug 10, 202614w ago 424B5 Mixed 6/10 Entry $52.69 to $53.77 Now $58.07 +10.21% ▲ +2.05% +3.11% vs SPY
  10. Aug 10, 202614w ago 8-K Mixed 6/10 Entry $52.69 to $53.77 Now $58.07 +10.21% ▲ +2.05% +3.11% vs SPY
Showing 10 of 17

US Market Status

Market Closed · Opens in 5h 30m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026